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Hepaticmalignancy
Extraskeletal osteosarcoma (EOS) is a rare entity. Most
human cases have been described in the soft tissues of the
limb.
1 Primary hepatic osteosarcoma is extremely uncom-
mon with only seven cases reported in the world’s literature.
Of these cases, no patient survived more than 8 weeks from
the time of diagnosis. We describe a young patient with a
symptomatic primary hepatic osteosarcoma that was suc-
cessfully treated by surgical resection and adjuvant chemo-
therapy. She is alive and tumor free 3 years after surgery.
Case Report
A healthy, athletic 19-year-old African American woman
presented for a surgical evaluation of a newly diagnosed
hepatic mass. The patient reported approximately 18 months
of occasional and intermittent episodes of epigastric
discomfort. Recently, she had developed symptoms of early
satiety and anorexia. On physical exam, she had vague
diffuse upper abdominal tenderness and a firm, palpable
mass in the left upper quadrant extending to the midline. A
calcified left upper quadrant mass was seen on abdominal
X-ray taken during an emergency room visit. Laboratory
evaluation was remarkable for moderate elevations of
alkaline phosphatase and alpha fetoprotein.
To further evaluate the mass, a CT scan of the chest,
abdomen, and pelvis was performed (Fig. 1), which showed
a large heterogeneous mass occupying the left lobe of the
liver with a 5-cm area of calcification in the anterior aspect.
MRI demonstrated a single heterogeneously enhancing 15×
10×13.8 cm lobulated mass inseparable from the left lobe
of the liver (Fig. 2). The left portal vein was not visualized
and there was no biliary dilatation. T1- and T2-weighted
sequences showed a 5-cm area of signal hypointensity
with multiple hypointense non-enhancing linear areas
throughout the mass consistent with areas of calcification.
A small amount of intraperitoneal free fluid was present.
Staging chest and brain CT demonstrated no evidence for
metastatic disease. Whole body Tc-99m MDP bone scan
demonstrated no evidence of skeletal metastatic disease.
The radiologic differential diagnosis includes sarcoma,
including metastatic osteosarcoma, and fibrolamellar hepa-
tocellular carcinoma.
At operation, a large, scarred lesion replacing the left
hepatic lobe was immediately identified. The lesion
extended across the falciform ligament into segment 4 of
the liver. It was also adherent to, but did not invade, the
stomach. The abdominal cavity was examined and no
metastatic deposits were noted. The right hepatic lobe was
examined with both palpation and intraoperative ultra-
sound, and was free of tumor. A left hepatic lobectomy was
performed with en-bloc cholecystectomy using a combina-
tion of electrocautery and hydrojet dissection. The middle
hepatic vein was not involved in the mass and was left in-
situ. Her post-operative recovery was uneventful. She was
discharged on the fifth post-operative day.
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mide and mesna at 14 g/m
2 for two courses followed by
cisplatin at 100 mg/m
2 with doxorubicin at 75 mg/m
2.
Chemotherapy courses were administered at 3-week inter-
vals. She received a total of four courses of ifosfamide and
two courses of cisplatin and doxorubicin with a cumulative
dose of doxorubicin of 150 mg/m
2. The patient has been
followed clinically as well as by serial CT imaging of her
abdomen, pelvis, and chest. She is alive without recurrence
36 months after surgery.
Pathologic examination of the left lobe resection
revealed a 15.0×13.8×12.0 cm, 1,390 g well-demarcated
non-encapsulated tan-gray rubbery intraparenchymal mass
with diffuse punctate hemorrhagic areas involving 95% of
the specimen (Fig. 3). A focal 5.5×4.5×4.5 cm gray-white
calcified area was present and a thrombus was in a large
portal vein. The surrounding liver parenchyma was tan-
brown and non-cirrhotic appearing. The specimen was
processed with formalin fixation and paraffin embedding.
Histological examination showed an undifferentiated
spindle cell neoplasm with foci of osteoid formation. The
calcified area was composed of multiple osteoid islands
circumferentially surrounded by undifferentiated malignant
spindle cells. These pleomorphic spindle cells were
characterized by indistinct cytoplasmic borders, vesicular
Figure 3 Cut surface of the resection specimen shows a tan-gray,
rubbery, firm well-demarcated tumor with multifocal areas of
hemorrhage and a thrombus at the right upper portion of the specimen.
The scale shows centimeters.
Figure 4 Malignant spindle cells with high mitotic activity, lacey
osteoid formation, and necrosis (H&E ×20).
Figure 2 Coronal T2-weighted MR demonstrating the lobulated
mass, predominantly hyperintense to liver. The calcified component
is hypointense.
Figure 1 Post-contrast axial CT demonstrates a heterogeneous mass
replacing the left lobe of the liver, hypoenhancing to liver parenchy-
ma, with areas of calcification. It displaces the stomach posteriorly
and inferiorly. The left portal vein is not visualized.
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membrane (Fig. 4). The spindle cells reacted with antibody
directed against vimentin and there was no immunostaining
for smooth muscle actin (SMA), S-100, desmin, epithelial
membrane antigen (EMA), CD 57, or AE1/3. A high
mitotic rate with greater than 80% staining for proliferative
marker Ki-67 was seen. Tumor was present in the portal
vein and in many intra-hepatic portal vein branches.
Discussion
Skeletal osteosarcoma is the most common malignant bone
tumor in children and adolescents. Modern multimodality
therapies including surgery and multiagent chemotherapy
have produced 60–70% 3-year survival rates.
2 Extraskeletal
osteosarcoma is a rare entity and case descriptions can be
found throughout the literature mostly in the limbs and limb
girdles.
3 Even fewer are reports of parenchymal osteosar-
coma, but such cases have been documented in thyroid,
kidney, gallbladder, breast, mesentery, liver, and colon.
4–10
In adults, primary sarcomas of the liver are very uncommon.
Attention has been focused particularly on angiosarcoma in
connection with thorotrast and polyvinyl chloride.
11 Cases
of primary hepatic fibrosarcoma and leiomyosarcoma
have been reported as have undifferentiated sarcomas,
though these tumors are seen almost exclusively in the
pediatric age group.
12 Primary osteosarcoma of the liver is
an exceedingly rare neoplasm of the liver which requires
that the presence of other neoplastic components be
excluded.
13 It is important to note that, after extensive
radiologic imaging and physical examination, no evidence
of a primary skeletal osteosarcoma was found in the
patient described in this report. Sumiyoshi and Niho
reported the case of a 52-year-old manwhowashospitalized
for hepatic failure.
14 He died 2 months after onset of
symptoms. Autopsy revealed a cirrhotic liver with a large
mass with histologic features of osteosarcoma. A literature
search revealed a total of seven cases of primary osteosarcoma
of the liver in humans and two case reports in animals.
8,13–20
We are unaware of a pre-operative diagnosis being made on
any patient with this disease. This may be related to the rarity
of the lesion or, alternatively, that if a biopsy were to return
osteoid in a large liver tumor, various more common tumors
would be suspected including hepatoblastoma, hepatic terato-
ma, malignant mesenchymoma, carcinosarcoma, hepatic
angiosarcoma, or other hepatic sarcoma. Moreover, when
mixed epithelial components are present, the pattern of
differentiation is essential to characterize the tumor. This
would be impossible with only a needle biopsy.
The age of patients with primary hepatic osteosarcoma
in prior reports ranged from 52 to 73 years. Each
previously described case resulted in either quick pro-
gression to death after diagnosis or the diagnosis was only
established at autopsy. This case is notable for the young
age at presentation (19 years old) and the prolonged
disease-free survival she has experienced following
surgery and adjuvant chemotherapy with multiagent
chemotherapy.
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